Search research articles
Contact Us
Filters
Showing results (341-350 of 385) with videos related to
Page
of 39
Sort By:
British Journal of Cancer
|
February 3, 2017
Asporin is a stromally expressed marker associated with prostate cancer progression
Annie Rochette, Nadia Boufaied, Eleonora Scarlata, et al.
The New England Journal of Medicine
|
October 21, 2011
Neighborhoods, obesity, and diabetes--a randomized social experiment
Jens Ludwig, Lisa Sanbonmatsu, Lisa Gennetian, et al.
Molecular Endocrinology (Baltimore, Md.)
|
August 18, 2012
Role of the HSP90-associated cochaperone p23 in enhancing activity of the androgen receptor and significance for prostate cancer
Vikash Reebye, Laia Querol Cano, Derek N Lavery, et al.
European Urology Open Science
|
October 1, 2020
Genetic Landscape of Prostate Cancer Conspicuity on Multiparametric Magnetic Resonance Imaging: A Systematic Review and Bioinformatic Analysis
Joseph M Norris, Benjamin S Simpson, Marina A Parry, et al.
British Journal of Cancer
|
July 25, 2013
Peroxiredoxin-3 is overexpressed in prostate cancer and promotes cancer cell survival by protecting cells from oxidative stress
H C Whitaker, D Patel, W J Howat, et al.
Journal of the American Academy of Dermatology
|
September 1, 1996
Guidelines of care for photoaging/photodamage. American Academy of Dermatology
L A Drake, S M Dinehart, E R Farmer, et al.
European Journal of Radiology
|
September 28, 2023
Prostate MR image quality of apparent diffusion coefficient maps versus fractional intracellular volume maps from VERDICT MRI using the PI-QUAL score and a dedicated Likert scale for artefacts
Saurabh Singh, Francesco Giganti, Louise Dickinson, et al.
Oncogene
|
November 19, 2013
N-acetyl-L-aspartyl-L-glutamate peptidase-like 2 is overexpressed in cancer and promotes a pro-migratory and pro-metastatic phenotype
H C Whitaker, L L Shiong, J D Kay, et al.
Endocrine-Related Cancer
|
January 7, 2015
HES5 silencing is an early and recurrent change in prostate tumourigenesis
Charles E Massie, Inmaculada Spiteri, Helen Ross-Adams, et al.
Prostate Cancer and Prostatic Diseases
|
November 23, 2024
Combining tissue biomarkers with mpMRI to diagnose clinically significant prostate cancer. Analysis of 21 biomarkers in the PICTURE study
Urszula Stopka-Farooqui, Vasilis Stavrinides, Benjamin S Simpson, et al.
Page
of 39
Search research articles
Search
Showing results (341-350 of 385) with videos related to
Sort By:
Page
of 39
British Journal of Cancer
|
February 3, 2017
Asporin is a stromally expressed marker associated with prostate cancer progression
Annie Rochette, Nadia Boufaied, Eleonora Scarlata, et al.
The New England Journal of Medicine
|
October 21, 2011
Neighborhoods, obesity, and diabetes--a randomized social experiment
Jens Ludwig, Lisa Sanbonmatsu, Lisa Gennetian, et al.
Molecular Endocrinology (Baltimore, Md.)
|
August 18, 2012
Role of the HSP90-associated cochaperone p23 in enhancing activity of the androgen receptor and significance for prostate cancer
Vikash Reebye, Laia Querol Cano, Derek N Lavery, et al.
European Urology Open Science
|
October 1, 2020
Genetic Landscape of Prostate Cancer Conspicuity on Multiparametric Magnetic Resonance Imaging: A Systematic Review and Bioinformatic Analysis
Joseph M Norris, Benjamin S Simpson, Marina A Parry, et al.
British Journal of Cancer
|
July 25, 2013
Peroxiredoxin-3 is overexpressed in prostate cancer and promotes cancer cell survival by protecting cells from oxidative stress
H C Whitaker, D Patel, W J Howat, et al.
Journal of the American Academy of Dermatology
|
September 1, 1996
Guidelines of care for photoaging/photodamage. American Academy of Dermatology
L A Drake, S M Dinehart, E R Farmer, et al.
European Journal of Radiology
|
September 28, 2023
Prostate MR image quality of apparent diffusion coefficient maps versus fractional intracellular volume maps from VERDICT MRI using the PI-QUAL score and a dedicated Likert scale for artefacts
Saurabh Singh, Francesco Giganti, Louise Dickinson, et al.
Oncogene
|
November 19, 2013
N-acetyl-L-aspartyl-L-glutamate peptidase-like 2 is overexpressed in cancer and promotes a pro-migratory and pro-metastatic phenotype
H C Whitaker, L L Shiong, J D Kay, et al.
Endocrine-Related Cancer
|
January 7, 2015
HES5 silencing is an early and recurrent change in prostate tumourigenesis
Charles E Massie, Inmaculada Spiteri, Helen Ross-Adams, et al.
Prostate Cancer and Prostatic Diseases
|
November 23, 2024
Combining tissue biomarkers with mpMRI to diagnose clinically significant prostate cancer. Analysis of 21 biomarkers in the PICTURE study
Urszula Stopka-Farooqui, Vasilis Stavrinides, Benjamin S Simpson, et al.
Page
of 39